Latest Press Releases
More Press Releases
IPTVZebraline Offers Global IPTV Subscription With 40000 Channels From 14.99 Per Month
IPTVZebraline is expanding its global IPTV subscription service, giving viewers worldwide access to over 40,000 live
Redemption Roofing AZ Expands Faith-Driven Roofing Services Across the Phoenix Valley
United States, 9th Apr 2026 – Homeowners and businesses throughout the Phoenix metropolitan area now have access to a
Paige Announces $2.5 Million Investment from 22nd State Banking Company
Strategic Community Bank Investment Fuels Expansion of Digital Legacy Planning Platform HOUSTON, TX / ACCESS Newswire /
B2BROKER Group Expands B2COPY into a Scalable Multi-Server Copy Trading Infrastructure with Transparent Pricing
DUBAI, United Arab Emirates, April 09, 2026 (GLOBE NEWSWIRE) — B2BROKER Group, providing global fintech solutions for
Beyond Meat® Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2025 Form 10-K Filing
EL SEGUNDO, Calif., April 09, 2026 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), otherwise known as Beyond The
New Era Energy & Digital Announces Pricing of $100 Million Public Offering of Common Stock
MIDLAND, Texas, April 09, 2026 (GLOBE NEWSWIRE) — New Era Energy & Digital, Inc. (“New Era” or the “Company”)
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”)
Everything Blockchain (OTC: EBZT) Acquires 10% Stake in NoLimit Foundation
NoLimit is building private, uncensored AI infrastructure for businesses that refuse to send their data to Big Tech
Aurora Mobile Debuts Modellix: A Unified Gateway for Next-Gen AI Media Generation
SINGAPORE, April 09, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers